Casting light on multiple sclerosis heterogeneity.....

Discuss topics relevant to gene therapy for MS here

Casting light on multiple sclerosis heterogeneity.....

Postby MSUK » Mon Mar 18, 2013 3:39 am

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology

Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome.

Spinal cord pathology is common and contributes significantly to disability in the disease.

The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is unknown..... Read More - http://www.ms-uk.org/index.cfm/genetics
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2114
Joined: Wed Oct 14, 2009 3:00 pm

Return to Gene Therapy

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service